211 related articles for article (PubMed ID: 31383240)
1. Sleep in
Méneret A; Roze E; Maranci JB; Dodet P; Doummar D; Riant F; Tranchant C; Fraix V; Anheim M; Ekmen A; McGovern E; Vidailhet M; Arnulf I; Leu-Semenescu S
J Clin Sleep Med; 2019 Jul; 15(7):1021-1029. PubMed ID: 31383240
[TBL] [Abstract][Full Text] [Related]
2. Oculomotor apraxia and disrupted sleep with nocturnal ballistic bouts in ADCY5-related disease.
Balint B; Antelmi E; Mencacci NE; Batla A; Eriksson SH; Walker MC; Bronstein AM; Bhatia KP
Parkinsonism Relat Disord; 2018 Sep; 54():103-106. PubMed ID: 29680308
[TBL] [Abstract][Full Text] [Related]
3. ADCY5-related dyskinesia: Broader spectrum and genotype-phenotype correlations.
Chen DH; Méneret A; Friedman JR; Korvatska O; Gad A; Bonkowski ES; Stessman HA; Doummar D; Mignot C; Anheim M; Bernes S; Davis MY; Damon-Perrière N; Degos B; Grabli D; Gras D; Hisama FM; Mackenzie KM; Swanson PD; Tranchant C; Vidailhet M; Winesett S; Trouillard O; Amendola LM; Dorschner MO; Weiss M; Eichler EE; Torkamani A; Roze E; Bird TD; Raskind WH
Neurology; 2015 Dec; 85(23):2026-35. PubMed ID: 26537056
[TBL] [Abstract][Full Text] [Related]
4. ADCY5-related dyskinesia - case series with literature review.
Kozon K; Łysikowska W; Olszewski J; Milanowski Ł; Figura M; Mazurczak T; Hoffman-Zacharska D; Koziorowski D
Neurol Neurochir Pol; 2024; 58(2):161-166. PubMed ID: 38230756
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Caffeine in ADCY5-Related Dyskinesia: A Retrospective Study.
Méneret A; Mohammad SS; Cif L; Doummar D; DeGusmao C; Anheim M; Barth M; Damier P; Demonceau N; Friedman J; Gallea C; Gras D; Gurgel-Giannetti J; Innes EA; Necpál J; Riant F; Sagnes S; Sarret C; Seliverstov Y; Paramanandam V; Shetty K; Tranchant C; Doulazmi M; Vidailhet M; Pringsheim T; Roze E
Mov Disord; 2022 Jun; 37(6):1294-1298. PubMed ID: 35384065
[TBL] [Abstract][Full Text] [Related]
6. ADCY5 mutation carriers display pleiotropic paroxysmal day and nighttime dyskinesias.
Friedman JR; Méneret A; Chen DH; Trouillard O; Vidailhet M; Raskind WH; Roze E
Mov Disord; 2016 Jan; 31(1):147-8. PubMed ID: 26686870
[No Abstract] [Full Text] [Related]
7. ADCY5-related dyskinesia presenting as familial myoclonus-dystonia.
Douglas AG; Andreoletti G; Talbot K; Hammans SR; Singh J; Whitney A; Ennis S; Foulds NC
Neurogenetics; 2017 Apr; 18(2):111-117. PubMed ID: 28229249
[TBL] [Abstract][Full Text] [Related]
8. Scoping Review on ADCY5-Related Movement Disorders.
Menon PJ; Nilles C; Silveira-Moriyama L; Yuan R; de Gusmao CM; Münchau A; Carecchio M; Grossman S; Grossman G; Méneret A; Roze E; Pringsheim T
Mov Disord Clin Pract; 2023 Jul; 10(7):1048-1059. PubMed ID: 37476318
[TBL] [Abstract][Full Text] [Related]
9. Depression and psychosis in ADCY5-related dyskinesia-part of the phenotypic spectrum?
Vijiaratnam N; Newby R; Kempster PA
J Clin Neurosci; 2018 Nov; 57():167-168. PubMed ID: 30172639
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic insights into ADCY5-associated disease.
Chang FC; Westenberger A; Dale RC; Smith M; Pall HS; Perez-Dueñas B; Grattan-Smith P; Ouvrier RA; Mahant N; Hanna BC; Hunter M; Lawson JA; Max C; Sachdev R; Meyer E; Crimmins D; Pryor D; Morris JG; Münchau A; Grozeva D; Carss KJ; Raymond L; Kurian MA; Klein C; Fung VS
Mov Disord; 2016 Jul; 31(7):1033-40. PubMed ID: 27061943
[TBL] [Abstract][Full Text] [Related]
11. ADCY5-related movement disorders: Frequency, disease course and phenotypic variability in a cohort of paediatric patients.
Carecchio M; Mencacci NE; Iodice A; Pons R; Panteghini C; Zorzi G; Zibordi F; Bonakis A; Dinopoulos A; Jankovic J; Stefanis L; Bhatia KP; Monti V; R'Bibo L; Veneziano L; Garavaglia B; Fusco C; Wood N; Stamelou M; Nardocci N
Parkinsonism Relat Disord; 2017 Aug; 41():37-43. PubMed ID: 28511835
[TBL] [Abstract][Full Text] [Related]
12. An Update on the Phenotype, Genotype and Neurobiology of ADCY5-Related Disease.
Ferrini A; Steel D; Barwick K; Kurian MA
Mov Disord; 2021 May; 36(5):1104-1114. PubMed ID: 33934385
[TBL] [Abstract][Full Text] [Related]
13. Deep brain stimulation reduces (nocturnal) dyskinetic exacerbations in patients with ADCY5 mutation: a case series.
de Almeida Marcelino AL; Mainka T; Krause P; Poewe W; Ganos C; Kühn AA
J Neurol; 2020 Dec; 267(12):3624-3631. PubMed ID: 32647899
[TBL] [Abstract][Full Text] [Related]
14. ADCY5 gene mutation: a case report.
Tezen D; Gunduz A; Erdemir Kiziltan M; Yalcinkaya C; Kiziltan G
Neurol Sci; 2022 Dec; 43(12):6947-6950. PubMed ID: 36112278
[TBL] [Abstract][Full Text] [Related]
15. Treatment of ADCY5-Associated Dystonia, Chorea, and Hyperkinetic Disorders With Deep Brain Stimulation: A Multicenter Case Series.
Dy ME; Chang FC; Jesus SD; Anselm I; Mahant N; Zeilman P; Rodan LH; Foote KD; Tan WH; Eskandar E; Sharma N; Okun MS; Fung VS; Waugh JL
J Child Neurol; 2016 Jul; 31(8):1027-35. PubMed ID: 27052971
[TBL] [Abstract][Full Text] [Related]
16. A de novo ADCY5 mutation causes early-onset autosomal dominant chorea and dystonia.
Carapito R; Paul N; Untrau M; Le Gentil M; Ott L; Alsaleh G; Jochem P; Radosavljevic M; Le Caignec C; David A; Damier P; Isidor B; Bahram S
Mov Disord; 2015 Mar; 30(3):423-7. PubMed ID: 25545163
[TBL] [Abstract][Full Text] [Related]
17. Cyclic alternating pattern as a provocative factor in nocturnal paroxysmal dystonia.
Terzano MG; Monge-Strauss MF; Mikol F; Spaggiari MC; Parrino L
Epilepsia; 1997 Sep; 38(9):1015-25. PubMed ID: 9579941
[TBL] [Abstract][Full Text] [Related]
18. Caffeine and the Dyskinesia Related to Mutations in the ADCY5 Gene.
Méneret A; Gras D; McGovern E; Roze E
Ann Intern Med; 2019 Sep; 171(6):439. PubMed ID: 31181574
[No Abstract] [Full Text] [Related]
19.
Kamate M; Mittal N
Neurol India; 2018; 66(Supplement):S141-S142. PubMed ID: 29503338
[No Abstract] [Full Text] [Related]
20. Respiratory sleep disturbance in children and adolescents with cystic fibrosis.
Silva AM; Descalço A; Salgueiro M; Pereira L; Barreto C; Bandeira T; Ferreira R
Rev Port Pneumol (2006); 2016; 22(4):202-8. PubMed ID: 27052354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
